Skip to content

Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention

A Patient-Caregiver Behavioral Intervention for Older Adults With Cancer and Mild Cognitive Impairment

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04826315
Enrollment
0
Registered
2021-04-01
Start date
2022-01-15
Completion date
2026-11-30
Last updated
2022-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cognitive Impairment

Keywords

Aging, Behavioral Intervention, Mental Health, Communication

Brief summary

The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of the dyad has cancer and mild memory difficulties and/or concerns. Participant and their spouse or participant and their family caregiver will have six, 60-minute video-conference sessions which will be scheduled at their convenience. The investigator will loan participants a tablet computer (iPad) to use for videoconferencing and train the participant in its use. Participant and their spouse or participant and their family caregiver will complete three assessments - one before starting the sessions, one after the sixth session, and one after 1 month. Each assessment will include surveys, which the participant will complete separately from their spouse or family caregiver. For most people, it will take upwards of 2 - 4 months to complete this study.

Interventions

BEHAVIORALCOPE +

Six sixty minute sessions that teaches participants distress and communication coping skills.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patient inclusion criteria include: 1. Patients with Stage I-IV breast, colon, rectal, or lung cancer (newly diagnosed within 6 months; age 65 or older. 2. Participants must be living at home (either in her/his own home). 3. Participants must be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions. 4. Exhibit Mild Cognitive Impairment. 5. Have an informal family caregiver. Inclusion Criteria: (Partner or family member) inclusion criteria include: 1. Caregivers are 18 older. 2. Be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions. 3. Either co-reside with the patient or spend at least 3-4 hours day caregiving. 4. Not exhibit cognitive impairment.

Exclusion criteria

for both patients and caregivers: 1. Participant has visual or hearing impairments that preclude participation. 2. Participant has dementia and do not have the capacity to participate. 3. Have a serious untreated psychiatric illness as documented in medical chart review. 4. The patient and the caregiver score less than a 3 on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) on a scale 0 to 10 to screen for distress.

Design outcomes

Primary

MeasureTime frameDescription
Number of completed sessions as measured by enrollment logUp to 10 weeks
Number of participants who are satisfied with the intervention as measured by a score of 24 or greater on the CSQ-8Up to 10 weeks.The Client Satisfaction Questionnaire (CSQ-8) is a self report measure of satisfaction with health and behavioral services received. The CSQ-8 is measured on a four point Likert scale from 1 Quite Dissatisfied to 4 Very Satisfied. Scores range from 8-32, with higher values indicating higher satisfaction.

Secondary

MeasureTime frameDescription
Change in Distress as measured by the DASS-21Up to 10 weeks.The Depression, Anxiety, and Stress Scale (DASS-21) measure will be used for rating general distress across three emotional states of depression, anxiety, and stress. The measure has a total of 21 items. Scores range from 0- 63, with higher scores indicating greater distress.
Change in Quality of Life as measured by the FACT-GUp to 10 weeks.The Functional Assessment of Cancer Therapy: General (FACT-G) measure will be used for rating quality of life. The measure has a total of 27 items. Scores range from 0-108, with higher scores indicating greater quality of life.
Change in Communication Patterns as measured by the CPQ-SFUp to 10 weeks.The Communication Patterns Questionnaire Short-Form (CPQ-SF) will be used for rating communication patterns in a relationship. The measure has a total of 11 items. Scores range from 11-99, higher scores indicate a greater likelihood of using a particular communication pattern during conflict interactions.
Change in Relationship Satisfaction as measured by the Mutuality Scale of the Family Care InventoryUp to 10 weeks.The Mutuality Scale of the Family Care Inventory will be used for rating mutual concerns and overall relationship satisfaction. The measure consists of 15 items. Scores range from 0-60, higher scores indicate greater relationship satisfaction.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026